Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Killelea

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Open Forum Infectious Diseases|March 10, 2022
Access to Medications for Opioid Use Disorder for Persons With Human Immunodeficiency Virus in the United States: Gaps in Coverage by State AIDS Drug Assistance ProgramsKathleen A McManus, Thibaut Davy-Mendez, Amy Killelea, et al.
American Journal of Public Health|September 20, 2019
Considerations for Modernized Criminal HIV Laws and Assessment of Legal Protections Against Release of Identified HIV Surveillance Data for Law EnforcementCarol L Galletly, Nanette Benbow, Amy Killelea, et al.
AIDS Research and Human Retroviruses|July 8, 2020
Assisters Succeed in Insurance Navigation for People Living with HIV and People at Increased Risk of HIV in a Complex Coverage LandscapeKathleen A McManus, Amy Killelea, Ethan Honeycutt, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|July 28, 2022
INTRODUCTION <b>Disrupting the Status Quo:</b> Building Equitable Access to HIV PrEP in the US through Innovative FinancingJeremiah Johnson, Amy Killelea, Derek T Dangerfield, et al.
AIDS Research and Therapy|November 20, 2024
Clustering affordable care act qualified health plans to understand how and where insurance facilitates or impedes access to HIV preventionSamuel D Powers, Karen M Schmidt, Amy Killelea, et al.
JAMA Network Open|June 4, 2020
Regional Disparities in Qualified Health Plans' Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United StatesKathleen A McManus, Samuel Powers, Amy Killelea, et al.
Open Forum Infectious Diseases|July 12, 2021
Worsening Disparities in State-Level Uptake of Human Immunodeficiency Virus Preexposure Prophylaxis, 2014-2018Samuel D Powers, Elizabeth T Rogawski McQuade, Amy Killelea, et al.
Preventive Medicine Reports|September 26, 2022
Economic benefits of the United States' AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy prioritiesKathleen A McManus, Andrew Strumpf, Amy Killelea, et al.
Journal of Pharmaceutical Policy and Practice|April 20, 2023
Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018-2020Rohan Khazanchi, Samuel Powers, Amy Killelea, et al.
JAMA Network Open|November 10, 2023
Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure ProphylaxisKathleen A McManus, Benjamin Fuller, Amy Killelea, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Open Forum Infectious Diseases|March 10, 2022
Access to Medications for Opioid Use Disorder for Persons With Human Immunodeficiency Virus in the United States: Gaps in Coverage by State AIDS Drug Assistance ProgramsKathleen A McManus, Thibaut Davy-Mendez, Amy Killelea, et al.
American Journal of Public Health|September 20, 2019
Considerations for Modernized Criminal HIV Laws and Assessment of Legal Protections Against Release of Identified HIV Surveillance Data for Law EnforcementCarol L Galletly, Nanette Benbow, Amy Killelea, et al.
AIDS Research and Human Retroviruses|July 8, 2020
Assisters Succeed in Insurance Navigation for People Living with HIV and People at Increased Risk of HIV in a Complex Coverage LandscapeKathleen A McManus, Amy Killelea, Ethan Honeycutt, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|July 28, 2022
INTRODUCTION <b>Disrupting the Status Quo:</b> Building Equitable Access to HIV PrEP in the US through Innovative FinancingJeremiah Johnson, Amy Killelea, Derek T Dangerfield, et al.
AIDS Research and Therapy|November 20, 2024
Clustering affordable care act qualified health plans to understand how and where insurance facilitates or impedes access to HIV preventionSamuel D Powers, Karen M Schmidt, Amy Killelea, et al.
JAMA Network Open|June 4, 2020
Regional Disparities in Qualified Health Plans' Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United StatesKathleen A McManus, Samuel Powers, Amy Killelea, et al.
Open Forum Infectious Diseases|July 12, 2021
Worsening Disparities in State-Level Uptake of Human Immunodeficiency Virus Preexposure Prophylaxis, 2014-2018Samuel D Powers, Elizabeth T Rogawski McQuade, Amy Killelea, et al.
Preventive Medicine Reports|September 26, 2022
Economic benefits of the United States' AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy prioritiesKathleen A McManus, Andrew Strumpf, Amy Killelea, et al.
Journal of Pharmaceutical Policy and Practice|April 20, 2023
Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018-2020Rohan Khazanchi, Samuel Powers, Amy Killelea, et al.
JAMA Network Open|November 10, 2023
Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure ProphylaxisKathleen A McManus, Benjamin Fuller, Amy Killelea, et al.
Pageof 2